Literature DB >> 3622506

Clostridium difficile-associated diarrhoea in uremic patients.

B Aronsson, P Barany, C E Nord, B Nyström, P Stenvinkel.   

Abstract

An outbreak of 94 episodes of Clostridium difficile-associated diarrhoea in 62 patients in a nephrology ward over a two-year period was investigated. Quantitative stool cultures were performed on ten uremic patients not on antibiotics and without diarrhoea and on ten healthy controls. All diarrhoeal episodes were associated with Clostridium difficile, and no other bacterial pathogens were isolated. Thirty-two relapses occurred in 16 patients, fourteen of the relapses without preceding antibiotic exposure. Clostridium difficile could not be isolated from the environment of the patients. Uremic patients, who had a significantly increased number of Clostridium spp. in their stools, are predisposed to Clostridium difficile infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622506     DOI: 10.1007/bf02017639

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  11 in total

1.  Relapse of pseudomembranous colitis after vancomycin therapy.

Authors:  W L George; N A Volpicelli; D B Stiner; D D Richman; E J Liechty; H Y Mok; R D Rolfe; S M Finegold
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

2.  Clostridium difficile colitis unassociated with antibiotic therapy.

Authors:  M E Ellis; B M Watson; P J Milewski; G Jones
Journal:  Br J Surg       Date:  1983-04       Impact factor: 6.939

3.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

4.  Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man.

Authors:  A Heimdahl; C E Nord
Journal:  Scand J Infect Dis       Date:  1979

5.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

6.  Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases.

Authors:  D W Milligan; J K Kelly
Journal:  J Clin Pathol       Date:  1979-12       Impact factor: 3.411

7.  Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species.

Authors:  I R Poxton; M D Byrne
Journal:  J Gen Microbiol       Date:  1981-01

8.  Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.

Authors:  K H Wilson; M J Kennedy; F R Fekety
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

9.  Occurrence of toxin-producing Clostridium difficile in antibiotic-associated diarrhea in Sweden.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

10.  Clostridium difficile-associated colitis in uremic patients.

Authors:  A C Leung; G Orange; A McLay; I S Henderson
Journal:  Clin Nephrol       Date:  1985-11       Impact factor: 0.975

View more
  11 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

Review 2.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

3.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

Review 4.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

Review 5.  The Risks of Incident and Recurrent Clostridium difficile-Associated Diarrhea in Chronic Kidney Disease and End-Stage Kidney Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Parkpoom Phatharacharukul; Charat Thongprayoon; Wisit Cheungpasitporn; Peter J Edmonds; Pailin Mahaparn; Jackrapong Bruminhent
Journal:  Dig Dis Sci       Date:  2015-05-19       Impact factor: 3.199

Review 6.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

7.  Clostridium difficile infection in patients with chronic kidney disease.

Authors:  Mira T Keddis; Sahil Khanna; Amit Noheria; Larry M Baddour; Darrell S Pardi; Qi Qian
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

Review 8.  Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review.

Authors:  Eroboghene H Otete; Anand S Ahankari; Helen Jones; Kirsty J Bolton; Caroline W Jordan; Tim C Boswell; Mark H Wilcox; Neil M Ferguson; Charles R Beck; Richard L Puleston
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

9.  Excess Mortality Attributable to Clostridium difficile and Risk Factors for Infection in an Historic Cohort of Hospitalised Patients Followed Up in the United Kingdom Death Register.

Authors:  Mark Reacher; Neville Q Verlander; Iain Roddick; Cheryl Trundle; Nicholas Brown; Mark Farrington; Philip Jones
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

10.  Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection.

Authors:  Sun Chul Kim; Min Young Seo; Jun Yong Lee; Ki Tae Kim; Eunjung Cho; Myung-Gyu Kim; Sang-Kyung Jo; Won-Yong Cho; Hyoung-Kyu Kim
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.